Home » loobobillyNPR » loobobilly News: Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic

Monday 20 January 2020

loobobilly News: Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic

at 20:04:00 Labels: Business , loobobillyNPR

Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic Drugs to treat multiple sclerosis can run $70,000 a year or more. Patients hoped competition from a generic version of one of the most popular brands would spur relief, but prices went up. Here's why. Drugs to treat multiple sclerosis can run $70,000 a year or more. Patients hoped competition from a generic version of one of the most popular brands would spur relief, but prices went up. Here's why. Business
Drugs to treat multiple sclerosis can run $70,000 a year or more. Patients hoped competition from a generic version of one of the most popular brands would spur relief, but prices went up. Here's why.

Read more on NPR